NMR spectroscopic studies on the metabolism and futile deacetylation of phenacetin in the rat

被引:10
作者
Nicholls, AW
Lindon, JC
Caddick, S
Farrant, RD
Wilson, ID
Nicholson, JK
机构
[1] UNIV LONDON BIRKBECK COLL,DEPT CHEM,LONDON WC1H 0PP,ENGLAND
[2] UNIV SUSSEX,SCH MOL & PHARMACEUT SCI,FALMER BN1,ENGLAND
[3] GLAXO WELLCOME RES & DEV LTD,MED RES CTR,PHYS SCI RES UNIT,STEVENAGE SG1 2NY,HERTS,ENGLAND
[4] ZENECA PHARMACEUT,DEPT SAFETY MED,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND
基金
英国工程与自然科学研究理事会;
关键词
D O I
10.1080/004982597239930
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. H-1-NMR spectroscopy of urine was used to determine the 0/,, deacetylation and re-acetylation of H-2-labelled (in the acetyl) phenacetin metabolites in the rat. 2. Male Sprague-Dawley rats were each dosed with either phenacetin or phenacetin-(CH3)-H-2 at 50 mg kg(-1). The total urinary recoveries for phenacetin and phenacetin-(CH3)-H-2 were 47.6+/-16.7 and 50.1+/-16.2% respectively (not significantly different, P > 0 05). Paracetamol sulphate and glucuronide are the major urinary metabolites of both protio and deuteriophenacetin. 3. The futile deacetylation given by the urinary recovery of protio-acetyl metabolites of phenacetin-(CH3)-H-2 was 29.6 +/- 0.9 % for paracetamol sulphate and 36.6 +/- 3.1 % for paracetamol glucuronide. These observations demonstrate a high level of futile deacetylation in the paracetamol conjugates formed by metabolism of phenacerin-(CH3)-H-2 and this may indicate a high metabolic flux through the nephrotoxic intermediate 4-aminophenol. 4. The level of futile deacetylation for phenacetin was significantly higher than that found previously in studies of labelled paracetamol in rat or man, and may be important in understanding the higher nephrotoxicity of phenacetin as compared with paracetamol.
引用
收藏
页码:1175 / 1186
页数:12
相关论文
共 24 条
[1]  
[Anonymous], 1996, CASARETT DOULLS TOXI
[2]  
BALES JR, 1985, CLIN CHEM, V31, P757
[3]  
BALES JR, 1984, CLIN CHEM, V30, P1631
[4]   DEACETYLATION OF PHENACETIN BY LIVER ESTERASE [J].
BERNHAMMER, E ;
KRISCH, K .
BIOCHEMICAL PHARMACOLOGY, 1965, 14 (05) :863-+
[5]  
BRODIE BB, 1949, J PHARMACOL EXP THER, V97, P58
[7]   MECHANISMS IN THE DEVELOPMENT OF ANALGESIC NEPHROPATHY [J].
DUGGIN, GG .
KIDNEY INTERNATIONAL, 1980, 18 (05) :553-561
[8]  
DUGGIN GG, 1993, ANALGESIC NSAID INDU, P5
[9]  
GARTLAND KPR, 1988, THESIS U LONDON
[10]  
GLOOR FJ, 1993, ANALGESIC NSAID INDU, P1